© 2001 by Oxford University Press
Journal of the National Cancer Institute, Vol. 93, No. 12, 951,
June 20, 2001
© 2001 Oxford University Press
CORRESPONDENCE |
Re: Comparison of Three Management Strategies for Patients With Atypical Squamous Cells of Undetermined Significance: Baseline Results From a Randomized Trial
Affiliations of authors: H. Strickler, Department of Epidemiology and Social Medicine, Albert Einstein College of Medicine, Bronx, NY; K. Shah, Department of Immunology and Infectious Diseases, The Johns Hopkins University, School of Hygiene and Public Health, Baltimore, MD.
Correspondence to: Howard Strickler, M.D., M.P.H., Department of Epidemiology and Social Medicine, Albert Einstein College of Medicine, 1300 Morris Park Ave., Belfer Bldg., Rm. 1308-B, Bronx, NY 10461 (e-mail: Strickle@aecom.yu.edu).
The Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Epithelial Neoplasia (ASCUS/LSIL) Triage Study (ALTS) is a milestone in efforts to determine the utility of human papillomavirus (HPV) DNA assays as an adjunct to primary cervical cytologic screening. Reporting for the ALTS investigators, Solomon et al. (1) present important data regarding
REFERENCES